"
A Study to Compare the Safety and Efficacy of Solifenacin, Tamsulosin and Tadalafil in Relieving Double-J Stent Related Symptoms"
written by Appiya Ramamoorthy Balaji, Pritam Pritish Patnaik, Javangula Venkata Surya Prakash, Sattanathan Vetrichandar, Krishnan Vembu Arasi, Arun Kumar Paranjothi, Vetrivel Natarajan,
published by
Open Journal of Urology,
Vol.10 No.3, 2020
has been cited by the following article(s):
|
[1]
|
Double-J stent-related lower urinary tract symptoms: a prospective randomized trial of mirabegron, solifenacin, tamsulosin, and tadalafil and their combinations
Gazzetta Medica Italiana Archivio per le Scienze Mediche,
2023
DOI:10.23736/S0393-3660.23.05006-4
|
|
|
|
|
[2]
|
Comparative effectiveness of Tamsulosin and Tadalafil therapy in ureteral stents-related symptoms (uSRS)
Medicina Clínica Práctica,
2021
DOI:10.1016/j.mcpsp.2021.100226
|
|
|
|